Technical analysis of Aethlon Medical, Inc. (AEMD): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses.
Price Performance
| 1 month | -49.83% |
| 3 months | -84.66% |
| Year-to-date | -89.53% |
| 1 year | -96.15% |
| 3 years | -99.86% |
| 5 years | -99.99% |
52-Week Range
| 52-week High | $41.35 |
| 52-week Low | $1.45 |
| Avg Volume (90d) | 820K |
Technical Indicators
| SMA 50 | $2.69 |
| SMA 200 | $9.32 |
| 30-day Volatility (annualised) | 92.3% |
| Price vs SMA 50 | -46.1% |
| Price vs SMA 200 | -84.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $26.30 | |
| 2025-11 | $22.20 | -15.6% |
| 2025-12 | $13.85 | -37.6% |
| 2026-01 | $12.50 | -9.7% |
| 2026-02 | $10.05 | -19.6% |
| 2026-03 | $10.95 | +9.0% |
| 2026-04 | $11.15 | +1.8% |
| 2026-05 | $11.05 | -0.9% |
| 2026-06 | $4.12 | -62.7% |
| 2026-07 | $3.31 | -19.7% |
| 2026-08 | $2.06 | -37.8% |
| 2026-09 | $1.45 | -29.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $1.43 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.09 |
| EV / EBITDA | 0.55 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.07 |
| Current Ratio | 5.42 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -34.28 |